Kernal Biologics
PrivateLast Round
Grant
Oct 7, 2025
Total Funding Raised
$25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kernal Biologics is a biotechnology company that develops mRNA-based immunotherapies for cancer and autoimmune diseases using AI-designed, cell-selective mRNA and targeted lipid nanoparticle technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kernal Biologics Comparables
Compare Kernal Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RNAimmune | 82% | |
| Strand Therapeutics | 81% | |
| HelixNano | 80% |
Kernal Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 7, 2025 | ||||
| Series A | Jul 7, 2022 |
Kernal Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amino Collective | Series A |
| HBM Healthcare Investments | Series A |
| Amgen Ventures | Series A |
| ARPA-H | Grant |
| Civilization Ventures | Series A |
| Hummingbird Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Grew 19% QoQ, from 16 to 19 employees.
- Oct 8, 2025
KR-402 is in development for B cell cancers.
Kernal Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kernal Biologics's valuation, stock price, and market status.
Is Kernalbio a public or private company?
Kernalbio is a private company.
What is the current stock price of Kernalbio?
Kernalbio is a private company with no public stock price. No recent secondary market data is available.
How much is Kernalbio worth (valuation)?
Valuation information for Kernalbio is not publicly available.
Can I buy Kernalbio stock?
Kernalbio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kernalbio's last funding round?
Kernalbio's most recent funding round was Grant on October 7, 2025.
Who are the main investors in Kernalbio?
Key investors in Kernalbio include Hummingbird Ventures.
Will Kernalbio IPO soon?
No public IPO plans have been announced for Kernalbio.
How can I track Kernalbio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kernalbio's secondary market activity and sign up for updates.